CJEU: Damage claim for unlawful provisional measures may be based on strict liability By Marcel Pemsel on Monday, January 22, 2024 C-473/22 CJEU compensation Enforcement Directive Gilead Marcel Pemsel mylan preliminary injunction preliminary ruling provisional measures strict liability trade marks TRIPS +
Reflections on IP exclusivity in the wake of the Corona virus outbreak By Léon Dijkman on Thursday, March 05, 2020 #IPKat compulsory license Corona virus COVID-19 exclusivity Gilead Lucrezia patents prize tarnishment trade marks Wuhan Institute of Virology +
The patent debate surrounding PrEP, the game-changer in HIV prevention By Dr Rose Hughes on Monday, September 02, 2019 AIDS Gilead HIV inter-partes review patents pharmaceutical IP PreP Rose Hughes Truvada us patents +
Would you like a side of Mr Justice Arnold on SPCs with your wind turbine? Teva v Gilead, Abraxis v Comptroller and Wobben v Siemens kick of 2017's patent cases By Annsley Merelle Ward on Thursday, January 26, 2017 AmeriKat article 3 CJEU reference Gilead medeva protected by a basic patent SPC regulation Teva +
Never Too Late: If you missed the IPKat last week! By Tian Lu on Wednesday, November 30, 2016 AG C-301/15 Soulier and Doke Gilead GS Media Haar house ban IP lawyer Tian Lu +
Entitlement to priority: Does Gilead confirm that it is a matter of substance over form? By Annsley Merelle Ward on Wednesday, November 16, 2016 AmeriKat Arnold J Court of Appeal Gilead Idenix Patent entitlement disputes priority +
Gilead triumphant as Court of Appeal upholds Arnold J in Idenix's Sovaldi appeal By Annsley Merelle Ward on Monday, November 14, 2016 added matter AmeriKat Arnold J Biogen insufficiency Court of Appeal Gilead Idenix insufficiency obviousness plausibility +
Idenix v Gilead - Patent profoundly invalid By Darren Smyth on Tuesday, December 02, 2014 claim construction Gilead HCV Idenix infringement inventive step novelty sofosbuvir; patent sufficiency validity +